Nizoral Shampoo Adverse Reactions

Clinical trial data: The safety of Nizoral Shampoo 2% was evaluated in 2890 subjects in 22 clinical trials where Nizoral Shampoo 2% was administered topically to the scalp and/or skin.
No adverse drug reactions (ADRs) were reported in ≥1% of Nizoral Shampoo 2%-treated subjects.
Adverse drug reactions that occurred in <1% of Nizoral Shampoo 2%-treated subjects in the clinical datasets are listed in Table 1. (See Table 1.)

Click on icon to see table/diagram/image

Post-marketing experience: Adverse drug reactions first identified during post-marketing experience with Nizoral Shampoo 2% are included in Table 2. In each table, the frequencies are provided according to the following convention: Very common ≥1/10; Common ≥1/100 and <1/10; Uncommon ≥1/1,000 and <1/100; Rare ≥1/10,000 and <1/1,000; Very rare <1/10,000, including isolated reports.
In Table 2, ADRs are presented by frequency category based on spontaneous reporting rates. (See Table 2.)

Click on icon to see table/diagram/image